Two new antibody treatments have shown promise in keeping high-risk Covid-19 patients out of the hospital. Now, federal and state health officials are urging patients and doctors to seek out the treatments. The two treatments, by Eli Lilly and Regeneron, are the first drugs developed specifically for Covid- to be authorized by the F.D.A. They consist of artificially synthesized copies of the antibodies that people produce naturally when their immune system fights off infection. Eli Lilly’s drug consists of one antibody.

Source: New York Times December 23, 2020 15:45 UTC